Quick hepatitis c test during mammograms could catch hidden cases

NCT ID NCT05067374

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study offered a rapid hepatitis C test to 1,500 women aged 50-74 who were already coming in for breast cancer screening in Montpellier, France. The goal was to see how many women would agree to the extra test and how many had undiagnosed hepatitis C. Women who tested positive were then connected to care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
rapid diagnostic orientation test (TROD) for hepatitis C
What this could lead to
If successful, this approach could help find undiagnosed hepatitis C cases in older women during routine breast cancer screening, supporting elimination goals.
What could go wrong
This is a completed observational study, not a treatment trial. It only tests screening feasibility, not whether finding cases improves health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beausoleil private clinic

    Montpellier, Occitanie, 34000, France

  • Lapeyronie radiology ward (Montpellier University hospital)

    Montpellier, Occitanie, 34000, France

  • Le Millénaire private clinic

    Montpellier, Occitanie, 34000, France

  • Victor Hugo Center

    Montpellier, Occitanie, 34000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.